Autism spectrum disorders (ASD) reflect a critical gap in medical care, often involving challenges in social communication, with limited treatments available for core symptoms. A key barrier to ...

Unlike traditional aligners, which often cause oral hygiene problems such as bacteria build-up, bad breath (halitosis) or cavities, Actival incorporates CSEM's patented 3D-printed microchannel ...

Swisspod is a Swiss-American company leading the development of the hyperloop technology. During Richard Branson's private ...

Switzerland has come out on top in three new studies. Both the World Intellectual Property Organisation (WIPO) and the consulting firm Roland Berger have crowned Switzerland the world champion of ...

Founded in 2018 and now located in Glattbrugg, Zurich, Menhir Photonics develops cutting-edge ultrafast lasers, providing innovative solutions for telecommunications, aerospace, and scientific ...

Alohi is on a roll. The Geneva-based technology start-up just won the prestigious Innovation Prize at the Grands Prix de l'économie, an event organized by the Chamber of Commerce, Industry and ...

Programs organized by global organizations including the United Nations, Bosch and Swiss Re have acknowledged the achievements of a Swiss startups, awarding them cash prizes and support to boost their ...

Aspivix has just added Tia, the US network of women's health clinics that is revolutionizing care through a more empathetic approach, to its ambassador program. With 26 centers of excellence around ...

Since 2016, Synpl Chem has been developing automated laboratory equipment for chemistry research, today serving customers worldwide including Novartis, AstraZeneca, Lilly and Bayer. The ETH spinoff ...

Experienced managers and prominent investors are joining Swiss start-ups. As a result, companies’ networks are becoming ever denser.

In another important milestone, PeriVision has signed a clinical trial agreement with Genentech, Roche's US business unit. The aim is to evaluate the potential use of the VisionOne platform in ...

Mabylon AG is a Schlieren-based biotechnology company at the forefront of human-derived antibody research, with a primary focus on allergies, neurological and inflammatory disorders. The company has ...